Comparative risk of malignancies and infections in patients with rheumatoid arthritis initiating abatacept versus other biologics: a multi-database real-world study

BACKGROUND: Patients with rheumatoid arthritis (RA) are at an increased risk of developing certain cancers and infections compared with the general population. Biologic and targeted synthetic disease-modifying antirheumatic drugs (b/tsDMARDs) are effective treatment options for RA, but limited evide...

Descripción completa

Detalles Bibliográficos
Autores principales: Simon, Teresa A., Boers, Maarten, Hochberg, Marc, Baker, Nicole, Skovron, Mary L., Ray, Nitesh, Singhal, Sanket, Suissa, Samy, Gomez-Caminero, Andres
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6839238/
https://www.ncbi.nlm.nih.gov/pubmed/31703717
http://dx.doi.org/10.1186/s13075-019-1992-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6839238/
https://www.ncbi.nlm.nih.gov/pubmed/31703717
http://dx.doi.org/10.1186/s13075-019-1992-x

Ejemplares similares